Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|January 13, 2006
Molecular lipophilicity determination of a huperzine series by HPLC: comparison of C18 and IAM stationary phasesFrançois Darrouzain, Philippe Dallet, Jean-Pierre Dubost, et al.
Bioorganic Chemistry|January 15, 2019
Synthesis, antioxidant and Aβ anti-aggregation properties of new ferulic, caffeic and lipoic acid derivatives obtained by the Ugi four-component reactionMohamed Benchekroun, Irene Pachón-Angona, Vincent Luzet, et al.
Scientific Reports|November 26, 2022
Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitroSébastien Pasquereau, Mathilde Galais, Maxime Bellefroid, et al.
Future Medicinal Chemistry|May 16, 2017
Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapyYoussef Dgachi, Helène Martin, Alexandre Bonet, et al.
Molecules (Basel, Switzerland)|July 17, 2020
Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease TherapyLazhar Zribi, Irene Pachòn-Angona, Òscar M Bautista-Aguilera, et al.
Frontiers in Neuroscience|July 23, 2016
ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease TherapyJosé Marco-Contelles, Mercedes Unzeta, Irene Bolea, et al.
Bioorganic Chemistry|August 26, 2019
Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapyRim Malek, Maciej Maj, Artur Wnorowski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 29, 2002
Triazine-human serum albumin association: thermodynamic approach and sodium effectLhassane Ismaili, Claire André, Laurence Nicod, et al.
Molecules (Basel, Switzerland)|March 30, 2016
Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease TherapyHoussem Boulebd, Lhassane Ismaili, Manuela Bartolini, et al.
European Journal of Medicinal Chemistry|November 30, 2010
Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonistsIsabelle Tomassoli, Lhassane Ismaili, Marc Pudlo, et al.
Pageof 6